Editorial on "heat shock protein peptide complex-96 (HSPPC-96) vaccination for recurrent glioblastoma: a phase II, single arm trial".
john.sampson@duke.edu.
John H
JH
Sampson
Gordana
G
Vlahovic
D001932:Brain Neoplasms / Q000188:drug therapy*; D019496:Cancer Vaccines / Q000627:therapeutic use*; D005260:Female; D005909:Glioblastoma / Q000188:drug therapy*; D006360:Heat-Shock Proteins / Q000627:therapeutic use*; D006801:Humans; D008297:Male
D019496:Cancer Vaccines; D006360:Heat-Shock Proteins; C484813:vitespin